UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 90

Sortiert nach

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints

Nature communications, 2016-02, Vol.7 (1), p.10501-10501, Article 10501

2016

Volltextzugriff (PDF)

Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression

Cancer cell, 2014-05, Vol.25 (5), p.590-604

2014

Volltextzugriff (PDF)

Tumor intrinsic and extrinsic functions of CD73 and the adenosine pathway in lung cancer

Frontiers in immunology, 2023-03, Vol.14, p.1130358-1130358

2023

Volltextzugriff (PDF)

Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors

Cancer discovery, 2013-12, Vol.3 (12), p.1355-1363

2013

Volltextzugriff (PDF)

Evasion of Innate Immunity Contributes to Small Cell Lung Cancer Progression and Metastasis

Cancer research (Chicago, Ill.), 2021-04, Vol.81 (7), p.1813-1826

2021

Volltextzugriff (PDF)

Interleukin-17A Promotes Lung Tumor Progression through Neutrophil Attraction to Tumor Sites and Mediating Resistance to PD-1 Blockade

Journal of thoracic oncology, 2017-08, Vol.12 (8), p.1268-1279

2017

Volltextzugriff (PDF)

Somatic LKB1 mutations promote cervical cancer progression

PloS one, 2009-04, Vol.4 (4), p.e5137-e5137

2009

Volltextzugriff (PDF)

Identification and characterization of an alternative cancer-derived PD-L1 splice variant

Cancer Immunology, Immunotherapy, 2019-03, Vol.68 (3), p.407-420

2019

Volltextzugriff (PDF)

A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer

Nature communications, 2024-01, Vol.15 (1), p.672-672, Article 672

2024

Volltextzugriff (PDF)

Comprehensive targeting of resistance to inhibition of RTK signaling pathways by using glucocorticoids

Nature communications, 2021-12, Vol.12 (1), p.7014-17, Article 7014

2021

Volltextzugriff (PDF)

Pulsatile MEK Inhibition Improves Anti-tumor Immunity and T Cell Function in Murine Kras Mutant Lung Cancer

Cell reports (Cambridge), 2019-04, Vol.27 (3), p.806-819.e5

2019

Volltextzugriff (PDF)

Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2

Nature communications, 2017-04, Vol.8 (1), p.14922-14922, Article 14922

2017

Volltextzugriff (PDF)

Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity

Journal for immunotherapy of cancer, 2019-02, Vol.7 (1), p.32-32, Article 32

2019

Volltextzugriff (PDF)

Multiple Interaction Domains in FtsL, a Protein Component of the Widely Conserved Bacterial FtsLBQ Cell Division Complex

Journal of Bacteriology, 2010-06, Vol.192 (11), p.2757-2768

2010

Volltextzugriff (PDF)

Author Correction: Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models

Nature communications, 2020-04, Vol.11 (1), p.1835-1835, Article 1835

2020

Volltextzugriff (PDF)

Kinase Domain Activation of FGFR2 Yields High-Grade Lung Adenocarcinoma Sensitive to a Pan-FGFR Inhibitor in a Mouse Model of NSCLC

Cancer research (Chicago, Ill.), 2014-09, Vol.74 (17), p.4676-4684

2014

Volltextzugriff (PDF)

Glucocorticoid mediated inhibition of LKB1 mutant non-small cell lung cancers

Frontiers in oncology, 2023-03, Vol.13, p.1025443-1025443

2023

Volltextzugriff (PDF)

Loss of Lkb1 Provokes Highly Invasive Endometrial Adenocarcinomas

Cancer research (Chicago, Ill.), 2008-02, Vol.68 (3), p.759-766

2008

Volltextzugriff (PDF)

Genomewide discovery and classification of candidate ovarian fertility genes in the mouse

Genetics (Austin), 2007-09, Vol.177 (1), p.179-194

2007

Volltextzugriff (PDF)

Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer

Nature (London), 2014-09, Vol.513 (7516), p.110-114

2014

Volltextzugriff (PDF)

1 – 25 von 90

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(88)

Publikationsform

Artikel
(89)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Life Sciences & Biomedicine
(42)
Humans
(35)
Animals
(32)
Mice
(28)
Oncology
(21)
Female
(17)
Lung Neoplasms - Drug Therapy
(15)
Lung Neoplasms - Genetics
(12)
Mutation
(12)
Tumors
(12)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(11)
Lung Cancer
(11)
Cell Biology
(10)
Disease Models, Animal
(10)
Male
(10)
Multidisciplinary Sciences
(8)
Pediatrics
(8)
Science & Technology - Other Topics
(8)
Cancer
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints

Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor

Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression

Tumor intrinsic and extrinsic functions of CD73 and the adenosine pathway in lung cancer

Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors

Evasion of Innate Immunity Contributes to Small Cell Lung Cancer Progression and Metastasis

Characterization of the Immune Landscape of EGFR-Mutant NSCLC Identifies CD73/Adenosine Pathway as a Potential Therapeutic Target

Interleukin-17A Promotes Lung Tumor Progression through Neutrophil Attraction to Tumor Sites and Mediating Resistance to PD-1 Blockade

Somatic LKB1 mutations promote cervical cancer progression

Identification and characterization of an alternative cancer-derived PD-L1 splice variant

Clinical implications of monitoring nivolumab immunokinetics in non-small cell lung cancer patients

A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer

Comprehensive targeting of resistance to inhibition of RTK signaling pathways by using glucocorticoids

Pulsatile MEK Inhibition Improves Anti-tumor Immunity and T Cell Function in Murine Kras Mutant Lung Cancer

Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2

Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity

D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice

Multiple Interaction Domains in FtsL, a Protein Component of the Widely Conserved Bacterial FtsLBQ Cell Division Complex

Author Correction: Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models

Kinase Domain Activation of FGFR2 Yields High-Grade Lung Adenocarcinoma Sensitive to a Pan-FGFR Inhibitor in a Mouse Model of NSCLC

Glucocorticoid mediated inhibition of LKB1 mutant non-small cell lung cancers

Loss of Lkb1 Provokes Highly Invasive Endometrial Adenocarcinomas

Genomewide discovery and classification of candidate ovarian fertility genes in the mouse

STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment

Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer

Suchergebnisse filtern